Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.12.05.627018

Modelling inter-shot variability for robust temporal sub-sampling of dynamic, GABA-edited MR spectroscopy data

Abstract

Variability between individual transients in an MRS acquisition presents a challenge for reliable quantification, particularly in functional scenarios where discrete subsets of the available transients may be compared. The current study aims to develop and validate a model for removing unwanted variance from GABA-edited MRS data, whilst preserving variance of potential interest - such as metabolic response to a functional task. A linear model is used to describe sources of variance in the system: intrinsic, periodic variance associated with phase cycling and spectral editing, and abrupt changes associated with subject movement. We broadly hypothesize that modelling these factors appropriately will improve spectral quality and reduce variance in quantification outcomes, without introducing bias to the estimates. We additionally anticipate that the models will improve (or at least maintain) sensitivity to functional changes, outperforming established methods in this regard. In vivo GABA-edited MRS data (203 subjects from the publicly available Big GABA collection) were sub-sampled strategically to assess individual components of the model, benchmarked against the uncorrected case and against established approaches such as spectral improvement by Fourier thresholding (SIFT). Changes in metabolite concentration and lineshape simulating response to a functional task were synthesized, and sensitivity to such changes was assessed. Composite models yielded improved SNR and reduced variability of GABA+ estimates compared to the uncorrected case in all scenarios, with performance for individual model components varying. Similarly, while some model components in isolation led to increased variability in estimates, no bias was observed in these or in the composite models. While SIFT yielded the greatest reductions in unwanted variance, the resultant data were substantially less sensitive to synthetic functional changes. We conclude that the modelling presented is effective at reducing unwanted variance, whilst retaining temporal dynamics of interest for functional MRS applications, and recommend its inclusion in fMRS processing pipelines. HighlightsO_LIA novel technique for modelling unwanted variance between transients is investigated. C_LIO_LISuitable covariate models yield improved SNR and reduced variability in GABA+ estimates from the resultant spectra. C_LIO_LIExtracted spectra remain sensitive to temporal dynamics of interest for functional MRS applications. C_LI Graphical AbstractIn dynamic MRS analysis, unwanted variability between transients may confound findings when sub-sampling within a single acquisition. We investigate covariate models and lineshape matching strategies to address this. We present composite models yielding improved quality metrics and within-scan repeatability while maintaining sensitivity to (synthetic) functional changes. O_FIG O_LINKSMALLFIG WIDTH=171 HEIGHT=200 SRC="FIGDIR/small/627018v1_ufig1.gif" ALT="Figure 1"> View larger version (48K): org.highwire.dtl.DTLVardef@174334forg.highwire.dtl.DTLVardef@1d4a500org.highwire.dtl.DTLVardef@19ce283org.highwire.dtl.DTLVardef@db2a29_HPS_FORMAT_FIGEXP M_FIG C_FIG

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Craven, A. R., Ersland, L., Hugdahl, K., Gruner, R.. 2024-12-09. Modelling inter-shot variability for robust temporal sub-sampling of dynamic, GABA-edited MR spectroscopy data. https://doi.org/10.1101/2024.12.05.627018

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗